Prognosticating Colorectal Cancer Recurrence using Machine Learning Techniques
暂无分享,去创建一个
Mehul Motani | Danliang Ho | Dawn Qingqing Chong | Brenda Tay | Iain Bee Huat Tan | M. Motani | I. Tan | D. Chong | D. Ho | Brenda Tay
[1] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[2] J. Wind,et al. Symptomatic and Asymptomatic Colon Cancer Recurrence: A Multicenter Cohort Study , 2016, The Annals of Family Medicine.
[3] A. Papalambros,et al. Predictors of survival in stage IV metastatic colorectal cancer. , 2010, Anticancer research.
[4] Neofytos Dimitriou,et al. A principled machine learning framework improves accuracy of stage II colorectal cancer prognosis , 2018, npj Digital Medicine.
[5] S. P. Akpabio. World Health Organisation , 1983, British Dental Journal.
[6] R. Gillies,et al. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study , 2018, PLoS medicine.
[7] M. Fararouei,et al. Risk Factors Predicting Colorectal Cancer Recurrence Following Initial Treatment: A 5-year Cohort Study , 2017, Asian Pacific journal of cancer prevention : APJCP.
[8] R. A. Baker,et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer , 1994, Diseases of the colon and rectum.
[9] Fernando Nogueira,et al. Imbalanced-learn: A Python Toolbox to Tackle the Curse of Imbalanced Datasets in Machine Learning , 2016, J. Mach. Learn. Res..
[10] Z. Hall. Cancer , 1906, The Hospital.
[11] Noam Auslander,et al. Predicting Complete Remission of Acute Myeloid Leukemia: Machine Learning Applied to Gene Expression , 2019, Cancer informatics.
[12] M. Gonen,et al. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome , 2017, JAMA oncology.
[13] Brian D Nicholson,et al. The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial , 2017, PloS one.
[14] Hans-Ulrich Prokosch,et al. Predicting Clinical Outcomes in Colorectal Cancer Using Machine Learning , 2018, MIE.
[15] Andreas W. Kempa-Liehr,et al. Time Series FeatuRe Extraction on basis of Scalable Hypothesis tests (tsfresh - A Python package) , 2018, Neurocomputing.
[16] M. Fakih,et al. CEA monitoring in colorectal cancer. What you should know. , 2006, Oncology.
[17] R. Lamerz,et al. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. , 2000, Anticancer research.
[18] M. Mai,et al. Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU. , 2005, Anticancer research.
[19] Rae Woong Park,et al. Development of Novel Breast Cancer Recurrence Prediction Model Using Support Vector Machine , 2012, Journal of breast cancer.
[20] T. Treasure,et al. The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer , 2014, BMJ Open.
[21] N. Armitage,et al. Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. , 1998, British Journal of Cancer.
[22] M. Duffy,et al. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? , 2001, Clinical chemistry.
[23] Jianjun Yang,et al. Machine Learning Algorithms for Predicting the Recurrence of Stage IV Colorectal Cancer After Tumor Resection , 2020, Scientific Reports.
[24] G. Yoon,et al. Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection , 2014, Annals of surgical treatment and research.
[25] N. Tahri,et al. [Sensitivity, specificity and prognostic value of CEA in colorectal cancer: results of a Tunisian series and literature review]. , 2001, La Tunisie medicale.
[27] G. Choi,et al. Serum Carcinoembryonic Antigen Monitoring After Curative Resection for Colorectal Cancer: Clinical Significance of the Preoperative Level , 2009, Annals of Surgical Oncology.
[28] M. Kanda,et al. Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) clinical trials , 2017, Journal of Cancer.